The vision and goal of Neopharm Group’s research and development arm, Neopharm Life Science Ventures (NLSV) is to conceive, incubate, and support pharmaceutical and biotechnology enterprises aiming to transform global healthcare by providing innovative solutions to medical practices.
NLSV helps to bridge the gap from early discovery to initial clinical proof-of-concept, working with global strategic partners for clinical registration, marketing, and distribution.
Committed to Performance
We invest substantially to ensure that our research is first-in-class, implementing the best possible technology to create life-changing therapies with strong patient value.
We select our targeted diseases based on unmet medical needs and the probability that our therapy can substantially impact the disease course and ultimately improve patient health.
A Prominent and Experienced Team
NLSV is led by a seasoned management team with a wealth of experience in the pharmaceutical and biotechnology industries.
Areas of Interest
NLSV’s Lead Program is focused on the development of innovative therapies, which positively transform the lives of patients suffering from rare, life-threatening diseases with unmet medical needs.
NLSV continuously seeks in-licensing opportunities for products targeting rare and ultra-rare diseases (< 200K prevalence in the U.S.) throughout all stages of development.
Profile of favorable licensing candidates:
- Known genetic abnormality
- High unmet need (life-threatening, chronically debilitating)
- Limited competition
- Clear endpoint achievable in reasonable time-frame
- All therapeutic areas